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Abstract
Background: Ankle exoskeletons can now reduce the metabolic cost of walking in humans without leg disability,
but the biomechanical mechanisms that underlie this augmentation are not fully understood. In this study, we
analyze the energetics and lower limb mechanics of human study participants walking with and without an active
autonomous ankle exoskeleton previously shown to reduce the metabolic cost of walking.
Methods: We measured the metabolic, kinetic and kinematic effects of wearing a battery powered bilateral ankle
exoskeleton. Six participants walked on a level treadmill at 1.4 m/s under three conditions: exoskeleton not worn,
exoskeleton worn in a powered-on state, and exoskeleton worn in a powered-off state. Metabolic rates were
measured with a portable pulmonary gas exchange unit, body marker positions with a motion capture system,
and ground reaction forces with a force-plate instrumented treadmill. Inverse dynamics were then used to
estimate ankle, knee and hip torques and mechanical powers.
Results: The active ankle exoskeleton provided a mean positive power of 0.105 ± 0.008 W/kg per leg during the
push-off region of stance phase. The net metabolic cost of walking with the active exoskeleton (3.28 ± 0.10 W/kg)
was an 11 ± 4 % (p = 0.019) reduction compared to the cost of walking without the exoskeleton (3.71 ± 0.14 W/kg).
Wearing the ankle exoskeleton significantly reduced the mean positive power of the ankle joint by 0.033 ± 0.006 W/kg
(p = 0.007), the knee joint by 0.042 ± 0.015 W/kg (p = 0.020), and the hip joint by 0.034 ± 0.009 W/kg (p = 0.006).
Conclusions: This study shows that the ankle exoskeleton does not exclusively reduce positive mechanical power at
the ankle joint, but also mitigates positive power at the knee and hip. Furthermore, the active ankle exoskeleton did
not simply replace biological ankle function in walking, but rather augmented the total (biological + exoskeletal) ankle
moment and power. This study underscores the need for comprehensive models of human-exoskeleton interaction
and global optimization methods for the discovery of new control strategies that optimize the physiological impact of
leg exoskeletons.
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Background
Only recently have exoskeletons been shown to reduce the
metabolic cost of human locomotion [1–4]. Reducing the
metabolic cost of legged locomotion is considered one of
the most important roles of a lower-extremity exoskeleton
[5, 6]. Even if reducing metabolic cost is not the primary
goal, designers of exoskeletal technologies must be able to
offset the detrimental impact of device mass and inertia.
Users may be willing to sacrifice modest increases in en-
ergy expenditure for devices that offer increased protec-
tion or capabilities, but even maintaining metabolic cost
requirements close to normal physiological levels is often
a difficult technological challenge. Additional mass added
to the body results in increased biological joint work and
metabolic rate. During level walking, Browning et al. [7]
showed that the metabolic increase associated with adding
mass to the foot is more than four times greater than
the same mass attached to the waist. Lower-extremity
exoskeletons counteract the effects of device mass through
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assistive exoskeletal forces and moments applied to the
body. The energy needed for locomotion is shared be-
tween the walking human and the worn exoskeleton with
the goal of maintaining or even lowering the human ener-
getic contribution as compared to normal physiological
levels required when the device is not worn.
Exoskeletons can be classified into two categories: passive
and active. Passive exoskeletons are often lightweight,
but due to their lack of power supply and electronics,
their controllability is limited [4, 8]. Active exoskeletons
generally implement electronic control systems that can
modulate exoskeletal behaviors for different conditions
[9, 10], including the adjustment of positive power to
the user [1–3, 11, 12]. Furthermore, exoskeletons can be
classified as either tethered or autonomous. Tethered exo-
skeletons require a connection (e.g., pressurized lines,
electrical wires) to an external mass not worn on the body,
typically an energy source or control hardware [1, 10]. Un-
like tethered exoskeletons, the entire system of an autono-
mous exoskeleton is worn by the user [3, 8, 13, 14], and
thus, autonomous exoskeletons are typically not limited to
a laboratory setting.
Passive exoskeletons have been shown to reduce the
metabolic cost of cyclic motions using lightweight designs
that store and release substantial amounts of strain energy.
In the study of Grabowski & Herr [8], a lightweight, pas-
sive exoskeleton was shown to significantly reduce the
metabolic cost of hopping by an average of 24 %. The hop-
ping exoskeleton used leg-parallel fiberglass leaf springs
between the user’s feet and hips to store and release en-
ergy. During each hop, approximately half of the required
eccentric and concentric leg work was provided by the
exoskeleton’s leg springs, likely reducing the metabolic
cost by reducing the mechanical muscle-tendon work.
The large elastic recoil and low device mass both contrib-
uted to the success of the hopping exoskeleton. The knee
joint in human hopping can be approximated as a tor-
sional spring, exerting minimal torque during full knee ex-
tension with torque increasing with increasing knee
flexion angle. In the study of Farris et al. [15], a passive
elastic ankle exoskeleton was shown to significantly reduce
the cost of hopping by 13 %. Wearing the elastic exoskel-
eton also resulted in both a reduction of soleus activation
and force generation, but a reduction in positive fascicle
power was not observed. The biomechanical profile of
hopping enables simple and lightweight exoskeletal de-
signs that can passively store elastic energy during knee
flexion and ankle dorsiflexion and then release that stored
energy during knee extension and ankle plantar flexion.
Recently, a passive ankle exoskeleton was shown to
reduce the metabolic cost of walking at 1.25 m/s by
7.2 % [4]. The exoskeleton used a steel coil spring and
a mechanical clutch connected to carbon fiber shank and
foot frames customized for each participant. Wearing a
moderately stiff spring resulted in a reduction of the
biological component of average ankle moment, positive
ankle power, and soleus muscle activation during the
stance phase of walking. Unlike the ankle, biological hip
and knee powers did not appear to change substantially
while wearing the exoskeleton.
Practical applications such as permanent assistive de-
vices and augmentative exoskeletons for recreation or
military purposes require autonomous devices where the
human wearer carries their own source of energy and
control. Such active autonomous leg exoskeletons have
been designed with the aim of augmenting running and
walking. Elliot et al. [9, 16] developed an autonomous
active exoskeleton for running using the observation that
the biological knee can be approximated as a spring dur-
ing the stance phase of slow to moderate-speed running.
Similar to the hopping exoskeleton of Grabowski & Herr
[8], the running exoskeleton also used fiberglass leaf
springs on the distal and proximal sides of the knee, but
the static knee joint of the hopping exoskeleton was re-
placed with a controllable, high-torque and lightweight
clutch. The articulated knee joint allowed the leg to
freely flex during the swing phase and then locked the
joint during stance to enable storage and release of
strain energy in the leg-parallel leaf springs. Upon evalu-
ation, the device was not shown to reduce the metabolic
cost of running. The authors argued [16] that the lack of
metabolic augmentation was due to the negative impact
of device added mass, poor human-device mechanical
energy transfer, and insufficient energy return from the
parallel leg springs.
In order to mitigate the effects of artificial joint align-
ment and device inertia, Asbeck et al. developed a soft
exosuit [12, 14]. Bowden cable actuators were mounted
outside of a backpack near the wearer’s pelvis to reduce
the added distal mass of the exoskeleton. The exosuit
used textiles and the actively controlled Bowden cables to
apply tensile forces in parallel with the lower-extremity
muscles. The Bowden cable was routed along the anterior
surface of the thigh, passing laterally across the knee axis of
rotation and then terminating at the heel. This mechanical
routing allowed the worn exoskeleton to simultaneously
apply hip flexion and ankle plantar flexion moments. Dur-
ing level ground walking, the powered exosuit was shown
to reduce the metabolic cost of walking when compared to
the powered-off exosuit [12]. However, it has not been
shown to reduce the metabolic cost of walking when com-
pared to the no exosuit condition, possibly a consequence
of the 10.1 kg system mass.
One effective strategy for reducing the mass of a worn
active exoskeleton is to move the energy source and
control hardware off the body [1, 10]. For example, the
worn mass of pneumatic exoskeletons can be reduced by
tethering the device to off-board compressed air and
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control valves. A tethered pneumatic ankle exoskeleton
was shown to reduce the metabolic cost of level-ground
walking by 6 % when compared to normal walking [1].
Tethered exoskeletons provide a means to study the ef-
fects of active exoskeletons with a high specific power,
but their range is limited to within the laboratory.
An autonomous active ankle exoskeleton was shown
to significantly reduce the metabolic cost of walking by
10 % [2], and the cost of loaded walking by 8 % [3]. The
device used a lightweight winch actuator to apply large
amounts of positive power to the ankle during the
powered plantar flexion phase of gait. The unidirectional
actuator prevented the device from impeding the user dur-
ing the swing phase and simplified the control strategy.
Although this autonomous exoskeleton has been shown
to reduce walking metabolism, the device’s impact on gait
biomechanics has not been adequately addressed. As au-
thors Galle et al. [11] have suggested, full kinematic and
kinetic data are needed to understand the biomechanical
impact of an metabolically-augmentative exoskeleton.
The purpose of this study is to investigate the bio-
mechanical impact of wearing an active autonomous
exoskeleton that has been previously shown to reduce
the metabolic cost of human walking [2]. The intent of
this research is to understand how the body cooperates
with an augmentative ankle device in order to inform
future exoskeletal control and hardware design. We
hypothesize that an ankle exoskeleton designed to assist
powered plantar flexion will reduce the metabolic cost of
walking by primarily reducing the mean positive ankle
power provided by the body. To evaluate this hypothesis,
six study participants walked on a level treadmill at 1.4 m/s
under three conditions: exoskeleton not worn, exoskeleton
worn in a powered-on state, and exoskeleton worn in a
powered-off state. Metabolic rates were measured with a
portable pulmonary gas exchange unit, body marker posi-
tions with a motion capture system, and ground reaction
forces with a force-plate instrumented treadmill. An inverse
dynamics calculation was then performed using the motion
capture and force plate data to estimate exoskeletal ankle
mechanics and biological ankle, knee and hip kinetics for
each walking condition. The resulting energetics and
biomechanics data are presented along with implications
for future exoskeleton design and control.
Methods
Exoskeleton
The active autonomous exoskeleton used in this study
was previously presented in [2]. The exoskeleton was
designed to minimize distal mass while maximizing
mechanical power output, efficiency and comfort. The
exoskeleton design relied on the support of the human
ankle to supply structure to the mechanism. The lack
of an artificial joint parallel to the human ankle joint
both reduced the device mass and eliminated the need
for joint alignment or the unwanted forces that might
arise from joint misalignment. In order to increase
comfort and efficiency, forces were only applied to the
shank and heel in (ideally) the direction normal to the
skin’s surface. The minimal amount of soft tissue on
the anterior aspect of the shank provided an efficient
area to transfer load between the exoskeleton and hu-
man body. Both the heel and shank are also capable of
comfortably withstanding substantial normal forces. The
bilateral exoskeleton consisted of pairs of fiberglass struts
attached to each boot, winch actuators on each shank
(Fig. 1), and a vest containing the batteries and motor
controllers.
Two fiberglass struts were attached to each boot to
create a large moment arm for the winch actuator. In
order to attach the struts, three holes, perpendicular to
the sagittal plane, were drilled into the sole of each boot:
one under the metatarsophalangeal joints and two under
the heel. Each strut measured approximately 380 mm
Fig. 1 Active autonomous ankle exoskeleton. The active autonomous ankle exoskeleton used a winch actuator on the shin to actuate the
proximal ends of fiberglass struts attached to the boot. The winch actuator implemented a brushless DC motor and pulley transmission to
wind a high strength cord. The motor controllers and batteries were worn around the chest and waist. Reflective markers on the strut were
used to measure the deflection of the struts and the applied exoskeletal torque
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long, 7 mm wide, and 5–20 mm thick. The shape of
the strut was designed to minimize mass by enforcing
near-constant surface strain on the anterior and posterior
faces, and avoiding lateral torsional buckling during actu-
ation. The distal ends of the struts were pinned to the
boots on the medial and lateral aspects of the metatarso-
phalangeal joints. Approximately 190 mm from the distal
end, the struts were attached to the heel of the boot with
an inextensible cord; the angle between the bottom of the
foot and struts was approximately 0.9 radians, creating a
moment arm of 230 mm. These strut dimensions were
held constant across all subject. The entire exoskeletal
structure attached to each boot was 190 g. The same
boot model (model: T180 X-Force, Wellco Enterprises,
Morristown, TN) was used for all walking conditions,
and had a mass of 750 g.
The autonomous exoskeleton used a pair of winch
actuators (one on each shin) to exert a plantar flexion
torque about the ankle. A 200 W brushless motor
(model: 305015, Maxon Motor, Sachseln, CH) actuated
an 8 mm diameter spool through a single stage pulley
transmission with a speed reduction of 44:14. The spool
wound up a high strength ultra-high-molecular-weight
polyethylene cord (1 mm diameter) to exert a force on the
proximal ends of the fiberglass struts. An aluminum hous-
ing constrained the motor, spool and idler pulleys. Al-
though the housing acted as a heat sink for the motor,
additional aluminum finned heat sinks were attached to
the motors, reducing the thermal resistance between the
motor housing and the environment. Custom 3D-printed
shin guards were used to distribute the force from the
winch actuator and support calf guards to protect the
medial and lateral sides of the leg from the proximal ends
of the struts. The shin guard also supported a single axis
(normal to the sagittal plane) gyroscope for gait phase de-
tection. The winch actuator had a mass of 870 g per leg.
In order to reduce distal mass, the batteries and motor
controllers were attached to a vest. The angular position
of each motor was measured by a 500 count quadrature
incremental optical encoder (model: HEDL 5540, Avago
Technologies, San Jose, CA). The actuators were con-
trolled by brushless motor controllers (model: SBL1360,
Roboteq, Scottsdale, AZ) that supported sensory acquisi-
tion, power electronics and the onboard microprocessor.
Two 24 V, 2.5 Ah, lithium-polymer batteries in series
powered the entire system. The mass of the batteries
and motor controllers was 1480 g, resulting in a total
device mass of 3600 g.
Due to the unidirectional nature of the winch actuator,
a finite state machine was used to apply assistance during
stance, and apply zero force during swing. The gyroscope
located on the shin was used to determine a swing event.
A swing event was detected if the shank underwent a pro-
longed period (over 220 ms) of protraction. A heel strike
was then estimated as occurring at the moment of retrac-
tion, when the shank angular velocity crossed through
zero. A heel strike event initiated cord tension and the
power timer. The actuator was controlled to apply a slight
plantar flexion torque to maintain cord tension until the
power timer expired (400–500 ms). After the power timer
expired, a parabolic voltage profile (with a peak of ap-
proximately 25 V) was applied to the ankle joint over
150 ms. The end of power assistance initiated the swing
phase, during which the actuator quickly released the cord
to not impede the user during dorsiflexion. The device
remained in a swing phase until the next heel strike was
detected. After each gait cycle (heel strike to heel strike),
an adaptive controller was used to adjust the power timer.
The power timer was automatically and incrementally ad-
justed during the trial so that the peak actuator power
would occur at 53 % gait cycle. The timing was selected to
align with literature values of ankle power timing [17].
Exoskeletal torque measurement
In order to simplify the exoskeletal design, reduce device
mass, and simplify data acquisition, the torque applied
to the ankle by the exoskeleton was measured by the
motion capture system. Five 6 mm reflective markers
were placed on each lateral fiberglass strut (Fig. 1). The
markers are denoted by mi, where i =1 is the most prox-
imal marker and i = 5 is the most distal marker. While
recording the position of the body markers, the motion
capture system simultaneously recorded the position of
the strut markers. Due to the flexibility of the struts, the
changing shape of the strut could be measured by ob-
serving the relative positions of the strut markers. The
shape of the strut was measured by projecting the five
marker positions, m1–5, onto the sagittal plane. The col-
lection of two-dimensional points were then rotated so
m1 and m5 would lie on the x-axis. A quadratic func-
tion, G(x) = g1x
2 + g2x + g3, was fitted to the five points
using the method of least squares. The component of
the string force perpendicular to the strut, F⊥, was esti-
mated as being proportional to the second derivative of





The unit direction parallel to the strut, û∥, was calcu-
lated as the normalized difference between the most












and the unit direction perpendicular to the strut, û⊥, is
simply a rotation of û∥,
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u^⊥ ¼ 0 1−1 0
 
u^∥: ð3Þ
The proximal tip of the strut, mt, was then estimated
as being 30 mm beyond the most proximal marker,
m→t ¼ m→5 þ 0:03 u^∥: ð4Þ
The unit direction of the string force, ûstring, was es-
timated as being a tension force in the unit direction
defined by the sagittal plane projection of the anterior
shank marker ms, and the proximal strut tip
u^string ¼ ms−mtjjms−mt jj: ð5Þ
With the proportional magnitude and direction of the
perpendicular strut force, and the string direction, the
string force, Fs, was estimated as
Fs ¼ a g1u^⊥⋅u^string þ b; ð6Þ
where a and b are experimentally determined constants.
The torque applied by the exoskeleton, τexo, was calculated
as the cross product of the moment arm and the estimated
string force,








where ma is the sagittal plane projection of the lateral
ankle joint marker. This method enabled a measurement
of exoskeletal torque that was synchronized with the hu-
man biomechanics at the minimal mass cost of five re-
flective markers per leg.
The constants a and b were experimentally determined
in a calibration experiment. An inline force sensor (model:
LRF350, Futek Advanced Sensor Technology Inc., Irvine,
CA), with its own reflective marker, was used to apply
various load conditions on the proximal tip of the struts.
The magnitude of force, direction of force, and frequency
of force were varied over approximately 60 s. The force
sensor and three-dimensional positions of the strut
markers and sensor marker were simultaneously mea-
sured. Using the methods described above, the applied
exoskeletal torque was estimated, and the force sensor
was used to directly measured the torque, τsensor, which
was calculated as the cross product of the moment arm
and the measured force, Fsensor,








In the calculation of ûstring, the marker on the force
sensor was used in place of the shank marker, ms. The
method of least squares was used to determine the
constants a and b from Eq. 6 that minimized the mean
square error between τexo and τsensor.
Experimental protocol
The biomechanical effects of the autonomous powered
exoskeleton were experimentally determined using six
study participants (6 male; 89 ± 8 kg body mass, 183 ± 6 cm
in stature; 27 ± 4 years old; mean ± standard deviation). All
subjects were healthy and exhibited no gait abnormalities.
This study was approved by the MIT Committee on the
Use of Humans as Experimental Subjects, and all of the
participants gave their informed consent after the nature
and possible consequences of the experiment were ex-
plained. The participants were asked to perform one stand-
ing trial and then four walking trials. Walking trials were
performed on a treadmill at a speed of 1.4 m/s, approxi-
mately the average adult walking speed [18]. Participants
were first asked to walk 10 min without the exoskeleton,
then 20 min with the active exoskeleton, 20 min with the
exoskeleton in a powered-off state, and finally, 10 min with-
out the exoskeleton. Walking experiments began and ended
without the exoskeleton to account for natural variations in
metabolism.
Data analysis and processing
The net metabolic cost of walking during each condition
was estimated by measuring the exchange of oxygen and
carbon dioxide during quiet standing and walking. Dur-
ing the standing and walking trials, participants wore a
portable pulmonary gas exchange measurement instrument
(model: K4b2, COSMED, Rome, IT). The measured ex-
change rates of oxygen and carbon dioxide along with the
equation developed by Brockway et al. were used to esti-
mate the metabolic rate [19]. The metabolic rate for a given
trial was determined by taking the mean rate over the last 5
min of the trial. The measurements made during the two
walking trials without the exoskeleton were averaged to de-
termine a single metabolic rate without the exoskeleton.
The metabolic rate measured while standing was subtracted
from the metabolic rates of walking in order to obtain the
net metabolic cost of walking.
Kinematic and kinetic data were simultaneously col-
lected with the metabolic measurements. To measure
kinematic and kinetic data, participants walked on a
\split-belt instrumented treadmill (Bertec, Columbus, OH)
within a motion capture volume. Each tread independ-
ently measured shear and vertical forces at a sampling rate
of 1000 Hz. Reflective markers (15 mm diameter) were
placed on the participant’s body at 46 locations, and their
three-dimensional locations were measured at a sampling
rate of 100 Hz by 12 infrared cameras (model: T40s, Vicon
Motion Systems Ltd, Oxford, UK). The locations of these
markers followed the Helen Hayes marker model, and
were chosen to track joint motion. Markers were not
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placed on the posterior side of the shank due to exoskel-
eton interference. Two pairs of boots (same model num-
ber) were used during the experiments; one pair while
walking with the powered and unpowered exoskeleton,
and one pair while walking without the exoskeleton. Fea-
tures on the boots were used to duplicate marker positions
as closely as possible. Five additional markers (6 mm) were
placed on each lateral fiberglass strut. These markers were
used to measure the applied exoskeletal torque and are
discussed in the previous section.
Various post-processing steps were performed to pro-
duce average kinematic and kinetic profiles for each
subject. The maker position data coupled with SIMM
software (Software for Musculoskeletal Modeling, Mus-
culographics Inc., Evanston, IL) were used to compute
joint angles. These kinematic data were then combined
with the force plate measurements and analyzed with
the SIMM Dynamics Pipeline to compute joint moment
profiles. A fourth order Butterworth filter with a 6 Hz
cutoff frequency was used to filter the kinematic data
[20], and a fourth order Butterworth filter with a 25 Hz
cutoff frequency was used to filter the force plate mea-
surements. Although SIMM provides a complete set of
profiles in three-dimensional space, only sagittal plane
motion was considered in this study.
Joint powers were calculated as the product of joint
velocity and joint torque, where positive power is defined
as joint or exoskeleton torque in the same direction as
joint velocity. Mean positive power was defined as the
time integral of positive power divided by the gait cycle
time, and mean negative power was defined as the time
integral of negative power divided by the gait cycle
time. During the active exoskeleton condition, total ankle
(biological + exoskeletal) moment and power were calcu-
lated by inverse dynamics. The biological contribution was
calculated by subtracting the exoskeletal contribution
from the total ankle value.
The kinematic and kinetic profiles were calculated for
the last 30 s of each walking trial. A heel strike was re-
corded if the vertical force on the tread exceeded 0.5 N
after a prolonged period (greater than 200 ms) of no
force, corresponding with a swing phase. Each 30 s trial
was divided into individual gait cycles that began and
ended with heel strike of the same foot, and then nor-
malized in time by percent gait cycle. Moments and
powers were also normalized by the subject’s body mass.
Gait cycles were discarded when the participant’s foot
simultaneously contacted both force plates. Mean joint
profiles (e.g., angle, moment, power) were calculated for
each leg during a trial. The right and left leg profiles
were then averaged together to calculate a subject’s mean
profile for a given trial. Furthermore, the two without exo-
skeleton trials were averaged together to create a single set
of without exoskeleton profiles. The mean profiles of each
subject were then used to calculate the intersubject mean
profile and standard error at each point in the gait cycle.
Individual scalar outcomes (e.g., mean powers, peak an-
gles, peak moments) were calculated from the mean
profile of each subject. The individual scalar outcomes
were then used to calculate the intersubject mean and
standard error.
Statistical analysis
We compared the metabolic cost of walking and scalar
biomechanical measures across the three conditions:
walking without an exoskeleton, walking with the active
exoskeleton and walking with the powered-off exoskel-
eton. We first performed a repeated-measures ANOVA
with the level of significance set at 0.05. The exoskeleton
condition was treated as a fixed factor and the subject was
treated as a random factor. When we found a significant
effect, post-hoc pairwise comparisons were made with a
Tukey honestly significant difference test, with the level of
significance set at 0.05.
Results
Torque measurement calibration
The relationship between the fiberglass strut’s shape and
the applied exoskeletal torque was experimentally deter-
mined with a digital force sensor. The applied exoskeletal
torque was varied between 0 and 70 Nm, at frequencies
between approximately 0 and 3 Hz. These input profiles
were chosen to be similar to the conditions experienced
during walking, since the force could not be directly
measured during walking. After performing calibration
experiments on both the right boot struts and the left
boot struts, the constants a and b from Eq. 6 were de-
termined to be
Fs ¼ 897 g1u^⊥⋅u^string −36; ð9Þ
with an R2 value of 0.97. The negative y-intercept is a re-
sult of the relaxed strut markers not being perfectly col-
linear and thus measuring a non-zero second derivative.
Using Eqs. 7, 8 and 9, the exoskeletal torque estimated
by the markers was compared to the exoskeletal torque
measured by the force sensor (Fig. 2). The root mean
square error of the exoskeletal torque was calculated to
be 3.2 Nm, or approximately 5 % of the peak measured
torque.
Metabolic cost and joint mechanics
The active ankle exoskeleton significantly reduced the
metabolic cost of walking. Net metabolic cost of walking
with the active exoskeleton (3.28 ± 0.10 W/kg) was an
11 ± 4 % (p = 0.019) reduction compared to the cost of
walking without the exoskeleton (3.71 ± 0.14 W/kg), and
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a 14 ± 3 % (p < 0.01) reduction compared to walking
with the powered-off exoskeleton (3.82 ± 0.13 W/kg). To
achieve this observed metabolic reduction, the exoskeleton
provided a mean positive power of 0.105 ± 0.008 W/kg to
the ankle joint, and a net power of 0.074 ± 0.006 W/kg.
Here all measurements are given as mean ± standard error.
In addition to reducing walking energetics, the device
altered walking biomechanics. For the three experimen-
tal conditions, the mean mechanical powers of the bio-
logical ankle, knee and hip joints are shown in Fig. 3.
Although the active exoskeleton did significantly reduce
the mean positive power of the biological ankle joint, it
also significantly reduced the mean positive power of
both the knee and hip joints. Compared to walking with-
out the exoskeleton, wearing the active exoskeleton sig-
nificantly reduced mean positive power of the
biological ankle by 0.033 ± 0.006 W/kg (p < 0.01), the
knee by 0.042 ± 0.015 W/kg (p = 0.02), and the hip by
0.034 ± 0.009 W/kg (p < 0.01). Also, compared to walking
without the exoskeleton, wearing the exoskeleton in a
powered-off state was not shown to significantly alter the
mean positive powers at the ankle, knee or hip.
The sum of biological joint powers and exoskeletal
power (during the active condition) were also compared
across experimental conditions. The results are shown in
Fig. 3. Wearing the active exoskeleton significantly
reduced the sum of biological joint mean positive powers
by 0.109 ± 0.025 W/kg (p < 0.01) when compared to the
no exoskeleton condition, but wearing the powered-off
exoskeleton did not have a significant effect (p = 0.838).
When the mean positive power of the exoskeleton was
added to the sum of biological mean positive powers dur-
ing the active exoskeleton condition, exoskeletal condition
was not observed to have a significant effect (ANOVA, p
= 0.833). These results show that the active exoskeleton
reduced the mean positive power of the biological muscle-
tendon system, but the mean positive power of the total
system (biological + exoskeleton) remained unchanged.
The mechanisms by which the exoskeleton affected the
biomechanics were investigated by comparing intersubject
mean joint angles, moments and power trajectories during
the different walking trials (Figs. 4, 5, and 6). Comparing
the kinematic and kinetic trajectories show both when and
how the exoskeleton affected the biomechanics of walking.
The kinematic changes caused by the active ankle exo-
skeleton were limited to the ankle joint (Fig. 4). Wearing
the active exoskeleton significantly reduced the magnitude
of the peak dorsiflexion angle of the biological ankle by
0.073 ± 0.014 radians (p < 0.01) when compared to the no
exoskeleton condition, but wearing the powered-off exo-
skeleton did not result in a significant change. Wearing
the active exoskeleton also led to an earlier onset of ankle
powered plantar flexion. Significant changes in the bio-
logical knee and hip angle trajectories were not observed.
A significant change in step period was also not observed.
Along with kinematic changes, the joint moment effects of
wearing the exoskeleton were measured (Figs. 5 and 6).
Compared to walking without the exoskeleton, wearing the
active exoskeleton decreased the magnitude of peak bio-
logical ankle powered plantar flexion moment by 0.19 ±
0.03 Nm/kg (p < 0.01). Interestingly, the magnitude of the
peak total ankle moment (biological + exoskeleton) during
the active exoskeleton condition was not significantly differ-
ent from the powered-off condition (p= 0.53), but both the
active and powered-off exoskeleton conditions were signifi-
cantly greater than the no exoskeleton condition by 0.25 ±
0.04 Nm/kg (p < 0.01) and 0.20 ± 0.05 Nm/kg (p < 0.01) re-
spectively. Compared with the no exoskeleton condition,
wearing the active exoskeleton also increased the peak knee
flexion moment during late stance by 0.11 ± 0.06 Nm/kg (p
< 0.01), and the peak hip flexion moment by 0.17 ± 0.05 Nm/
kg (p < 0.01), but reduced the magnitude of the peak hip ex-
tension moment by 0.090 ± 0.04 Nm/kg (p= 0.041). The
peak knee and hip moments while wearing the powered-off
exoskeleton were not observed to be significantly differ-
ent from the no exoskeleton condition.
The ankle angle and torque changes resulted in sig-
nificant changes of the ankle power profile (Fig. 5).
Compared to the no exoskeleton condition, the peak
biological ankle power was not significantly affected by
Fig. 2 Strut torque characterization. The exoskeletal torque measured
by a force sensor and motion capture system were compared to the
exoskeletal torque predicted by the deflection of the struts. Using
reflective markers on the strut enabled a simple, synchronous method
for measuring exoskeletal torque without adding substantial mass. The
system was calibrated at various amplitudes and frequencies, similar to
those experienced during walking. Only a portion of the calibration
data are shown in the figure
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the active exoskeletal condition (ANOVA, p = 0.63), but
the magnitude of the peak negative biological ankle
power was reduced by 0.48 ± 0.10 W/kg (p < 0.01) when
wearing the active exoskeleton, and not significantly af-
fected when wearing the powered-off exoskeleton. Similar
to the peak total ankle moment, the peak total ankle power
(biological ankle + exoskeleton) was significantly increased
by 1.02 ± 0.14 W/kg (p < 0.01) while wearing the active
exoskeleton, but the magnitude of the peak negative
total ankle power was similar to the biological ankle.
While wearing the active exoskeleton both the bio-
logical ankle and total ankle power profiles became
positive and peaked earlier than the powered-off and
no exoskeleton conditions.
Discussion
Autonomous leg exoskeletons have now been shown to
reduce metabolic demand in level ground walking, but the
biomechanical mechanisms underlying such reductions
have not been elucidated. In this study, we hypothesize
that an ankle exoskeleton designed to assist powered plan-
tar flexion will reduce the metabolic cost of walking by
primarily reducing the mean positive ankle power pro-
vided by the body. The results of this study do not support
the hypothesis. In addition to reducing the mean positive
power of the biological ankle, the ankle exoskeleton sub-
stantially reduced both the biological knee and hip mean
positive powers. The reduction of mean positive power at
all three biological joints suggest that the powered exo-
skeleton was not only reducing the work done by muscles
local to the ankle, but altering the gait to reduce the
work done by the larger, more proximal muscles span-
ning the knee and hip.
The fact that the active ankle exoskeleton impacted
muscle function spanning the knee joint is not unexpected
given the results of Galle et al. [11]. These researchers
Fig. 3 Exoskeletal effects on mean joint powers. The mean net powers, mean positive powers, and mean negative powers of the biological ankle,
knee, hip and sum of all three joints are shown while wearing no exoskeleton (grey), the powered-off exoskeleton (blue), and the active exoskeleton
(red). The black bars also include the mechanical exoskeletal power. Vertical error bars represent the standard error means, and horizontal brackets
denote conditions that are significantly different (p < 0.05)
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measured muscle EMG on study participants walking
uphill wearing an active ankle exoskeleton designed to
assist powered plantar flexion [11]. They showed that
the EMG RMS amplitude was significantly reduced in
musculature spanning the knee, namely the vastus lateralis
and biceps femoris. The electromyography of these knee
muscles was reduced during early stance for the experi-
mental condition of the ankle exoskeleton powered-on, as
compared to the powered-off condition.
Mechanical energetics of the biological joints plus
exoskeletal system
Although the principle the body employs to distribute
exoskeletal power across the human musculoskeletal sys-
tem is unknown, wearing the active exoskeleton did not
significantly change the system (ankle + knee + hip + exo-
skeleton) mean power. When comparing the system of the
ankle, knee and hip biological leg joints plus the powered
ankle exoskeleton to only these biological leg joints while
not wearing the exoskeleton, there was no significant differ-
ence found in the system mean net power, mean positive
power, or mean negative power. In other words, the positive
and negative mean mechanical power provided by the exo-
skeleton replaced positive and negative mean mechanical
power at the biological joints.
Biological plus exoskeletal ankle joint augmentation
The results of this study show that the impact of the active
ankle exoskeleton was not to simply replace biological ankle
function in walking, but rather to augment the total (bio-
logical + exoskeletal) ankle moment and power. While wear-
ing the exoskeleton, the total ankle moment and power is
defined as the sum of the contributions from the biological
ankle and the exoskeleton. If the exoskeleton were to simply
replace the biological ankle function, one would expect the
peak total ankle power and the magnitude of the peak total
Fig. 4 Joint angle profiles. The angle trajectories of the ankle, knee and hip are shown over a gait cycle that begins and ends with heel strike of
the same leg. Increasing angles represent dorsiflexion at the ankle, flexion at the knee, and flexion at the hip. The trajectories are intersubject
means. The grey solid lines represent the no exoskeleton condition; dark blue dashes represent the powered-off exoskeleton condition, and the
red dots represent the active exoskeleton condition. The standard error means are shown with light shading of the same color
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ankle moment to not change compared to the no exoskel-
eton condition. However, wearing the active exoskeleton
caused both the peak total ankle power and the magnitude
of the peak total ankle moment to increase during stance. A
significant difference in the peak biological ankle power was
not detected during the different conditions.
These results are in contrast with the results of Collins
et al. [4]. They showed that the peak total ankle power
decreased while wearing a passive ankle exoskeleton,
and the magnitude of the peak total ankle moment was
unaffected by wearing the device. Their passive ankle
exoskeleton also reduced the peak biological ankle power.
Although both the device of Collins et al. [4] and the de-
vice evaluated in this study were designed to assist ankle
plantar flexion, distinct human adaptations emerged upon
testing each exoskeletal system. These distinct adaptations
are consistent with the findings of Jackson and Collins
[21], who measured the effects of a tethered unilateral
ankle exoskeleton during different power and torque
conditions. They observed that the peak total ankle power
increased when the exoskeleton provided medium and
high amounts of net work, but the peak total ankle power
decreased when the device provided zero or negative net
work. These findings by Jackson and Collins [21] are
consistent with the active ankle exoskeleton of this
study increasing peak total ankle power and the passive
ankle exoskeleton of Collins et al. [4] reducing peak total
ankle power.
Implications for Exoskeleton Design
In this study, we hypothesized that the ankle exoskeleton
would predominantly replace ankle function, although
Fig. 5 Ankle moment and power profiles. The ankle moment profiles during the first 70 % of the gait cycle are depicted on the top graph, and
the ankle power profiles are depicted on the bottom. Positive moment values denote ankle dorsiflexion. The figure compares the biological ankle
during the no exoskeleton condition (grey solid line), the powered-off exoskeleton condition (dark blue dashes), and the active exoskeleton condition
(red dots). The exoskeleton moment and power during the active condition are shown with light blue dashes and dots. The sum of the biological ankle
and exoskeleton during the active condition are shown with a solid black line with dots. The standard error means are shown with light shading of the
same color
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the effects of the device are more global and nuanced
than had been initially anticipated. If the device only re-
placed ankle power, then one would expect the upper
boundary of augmentation to be complete replacement
of the biological ankle torque. However, if only part of
the exoskeletal power is used to lower the biological ankle
power and a significant amount is also used to lower the
knee and hip biological powers, then it may be possible to
achieve even greater metabolic augmentation levels by ap-
plying power to the exoskeletal ankle that is greater than
the natural biomechanical values observed during un-
assisted locomotion. This idea is also supported by a previ-
ous study on non-amputees wearing prosthetic ankles that
showed the metabolic rate continued to decrease even
after the ankle power was well beyond a natural level [22].
If this phenomenon extends to ankle exoskeletons, many
design benefits could be achieved. First, a single ankle
joint exoskeleton that aids multiple biological joints is a
simpler and likely lighter solution than a multi-joint exo-
skeleton. Second, the ankle is an ideal leg joint to supply
exoskeletal power since the shin, heel and ground can all
comfortably withstand large exoskeletal forces. It is more
difficult to efficiently and comfortably apply external loads
to the thigh and torso where there are greater amounts of
soft tissue.
The biomechanical effects of the ankle exoskeleton sug-
gest that the optimal control strategy to minimize meta-
bolic energy consumption may not be to simply emulate
the biological ankle behaviour observed during natural un-
assisted gait. To develop such an optimal control strategy,
a full biophysical model of the lower-extremities would
prove critically important. Such a model would allow
Fig. 6 Knee and hip moment and power profiles. The knee and hip moment and power profiles are compared during the three exoskeletal
conditions. Positive moment values denote flexion at the knee and flexion at the hip. The moment profiles are shown on top and the power
profiles are shown on the bottom. The knee profiles are on the left and the hip profiles are on the right. The grey solid lines represent the no
exoskeleton condition; dark blue dashes represent the powered-off exoskeleton condition, and the red dots represent the active exoskeleton
condition. The standard error means are shown with light shading of the same color
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researchers to predict the biomechanical and metabolic
effects of externally-applied exoskeletal forces and masses.
The model would likely have to capture muscle morpholo-
gies, muscle-tendon interactions, neural reflexes and neural
adaptations. Indeed, if such a model existed, researchers
could determine optimal exoskeletal torque trajectories to
minimize walking metabolism. The maximal metabolic re-
duction possible with such an optimal ankle exoskeleton
may be even larger than the metabolic contribution of the
biological ankle during normal, unassisted walking.
Augmentation Factor
The Augmentation Factor (AF) was proposed as a simple
model that aims to approximate the metabolic impact of a
lower-extremity exoskeleton [3]. The AF balances the meta-
bolic costs associated with the added device mass and net
energy removed from the human system, with the beneficial
effects of providing the user with positive mechanical power.
The results of this study support a fundamental assumption
of the Augmentation Factor [3], namely that positive mech-
anical exoskeletal power is used by the body to replace posi-
tive muscle-tendon power. However, a limitation of the AF
is that it does not provide insight into the specific joints or
muscles that are affected by assistive exoskeletal power.
Future design improvements
Improvements to the autonomous exoskeleton may re-
sult in even larger metabolic reductions. The shifting
of the biological ankle power profile suggests that the
exoskeleton may be applying power too early. An ad-
justment in the power timing, or a non-timing based
controller, may result in a more economical use of
exoskeletal power. It also appears that the amplitude
of the applied power could be substantially higher,
even exceeding biological levels. A higher transmission
ratio or different motor topology should enable additional
power. It may also be possible to tune the stiffness of the
fiberglass struts to increase the overall efficiency and
enable greater power output. Finally, reducing device mass
is always a goal and likely to improve performance.
Conclusion
In this study, an active autonomous ankle exoskeleton
reduced the metabolic cost of level ground walking. The
biomechanical mechanism for this observed metabolic
reduction is not only a mechanical power reduction at
the biological ankle, but also an observed reduction at
the biological knee and hip, as compared to walking
without the exoskeleton. The sharing of exoskeletal power
between biological joints suggests that ankle exoskeletons
may be capable of greater metabolic reductions than pre-
viously thought. The capacity of an ankle exoskeleton to
also augment the knee and hip greatly expands the oppor-
tunity for practical application.
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